Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast

One hundred and sixteen patients with locally advanced or metastatic breast cancer were randomized to receive CMF (cyclophosphamide 600 mg m(−2) day 1 and 8 i.v., 5-fluorouracil 600 mg m(−2) day 1 and 8 i.v.,, methotrexate 40 mg m(−2) day 1 and 8 i.v., monthly for 6 cycles) or MM (methotrexate 30 mg...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Harper-Wynne, C, English, J, Meyer, L, Bower, M, Archer, C, Sinnett, H D, Lowdell, C, Coombes, R C
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1999
Témata:
Regular Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362871/
https://ncbi.nlm.nih.gov/pubmed/10496359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6990694
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky